I’m a buyer-focused supplier of advanced hemorrhoids laser systems. This diode laser 15 watt 980nm for hemorrhoids is compact, powerful, and designed for fast recovery in laser hemorrhoid treatment. I’ve seen clinics use this laser for laser hemorrhoid surgery because it delivers precise cutting and coagulation with minimal tissue damage. The laser used in hemorrhoid procedures is safe, reliable, and easy to integrate with existing surgery suites. Our hemorrhoids diode laser system uses a vascular laser diode h technology for controlled hemostasis and reduced downtime. With Cheap pricing and dependable Service, I can help your facility upgrade to a proven tool for laser hemorrhoid treatment and to win more patients who seek quick, comfortable relief from hemorrhoids. Whether you’re performing laser hemorrhoid treatment or need a standby device for laser hemorrhoids diode laser applications, this system supports efficient workflows, clear visualization, and great after-sales service.
As global procurement eyes the next generation of minimally invasive solutions, the 980 nm diode laser at 15 W stands out for hemorrhoidal treatment. Its target-selective photothermal effect delivers precise coagulation with minimal collateral damage, enabling effective laser hemorrhoid treatment and outpatient procedures. The compact, fiber-delivered system supports fast turnaround, reduced anesthesia needs, and quicker recovery for patients. When evaluating devices for procurement, buyers should consider wavelength stability, power consistency, pulse mode options, cooling, and ergonomic handpieces. Compatibility with standard endoscopy platforms, sterilization cycles, single-use versus reusable components, and service networks are critical. Regulatory clearances, after-sales support, spare parts, training, and upgrade paths influence total cost of ownership and uptime. By 2025, innovations converge on intelligent control, programmable pulse sequences, real-time feedback, and integrated documentation that simplify outcomes reporting. Global suppliers should offer robust warranties, comprehensive training, and scalable configurations to meet diverse clinics—from urban centers to rural hospitals—while delivering safety, efficiency, and patient satisfaction.
| Dimension / Parameter | Description | Typical Value | Unit | Notes |
|---|---|---|---|---|
| Wavelength | Laser diode wavelength used for hemorrhoid therapy | 980 | nm | Common diode wavelength in hemorrhoid devices |
| Emission Mode | Operational mode of laser output | Continuous Wave (CW) / Pulsed | - | Device may support CW or pulsed modes |
| Output Power | Nominal laser output power | 15 | W | Typically adjustable on many devices |
| Pulse Duration | Pulse duration if pulsed mode is used | 0.5-2.0 | ms | Short pulses help minimize collateral damage |
| Spot Size | Laser spot size at tissue target | 0.4-1.0 | mm | Adjustable via focusing optics |
| Delivery Method | How laser is delivered to tissue | End-fire fiber catheter | - | Flexible fiber enables precise targeting |
| Applications | Target tissue and hemorrhoid types | External/Internal; Grades II–III | - | Suitable for prolapse-related symptoms |
| Mechanism | Primary tissue interaction | Photothermal coagulation with limited ablation | - | Causes tissue shrinkage and vessel coagulation |
| Procedure Duration | Typical session length | 15-30 | minutes | Depends on extent of prolapse and number of sites |
| Anesthesia | Type of anesthesia commonly used | Topical local | - | General anesthesia rarely required |
| Efficacy / Symptom Relief | Expected short-term relief rate | 70-90 | % | Varies by patient and lesion grade |
| Safety / Complications | Incidence of adverse events | 2-5 | % | Usually minor; erythema or transient discomfort; bleeding is rare |
| Recovery Time | Time to resume normal activity | 1-7 | days | Most patients return within a week |
| Repeat Sessions | Need for additional treatments | 1 | sessions | Some cases may require second session |
| Tissue Depth / Penetration | Depth of tissue effect | 1-3 | mm | Targets superficial mucosal layers |
| Regulatory Status | Regulatory clearance in regions | CE/FDA clearance | - | Device readiness varies by market |